Stay updated on Budesonide in Eosinophilic Esophagitis Maintenance Trial

Sign up to get notified when there's something new on the Budesonide in Eosinophilic Esophagitis Maintenance Trial page.
Latest website image capture
Clouds background image

Latest updates to the Budesonide in Eosinophilic Esophagitis Maintenance Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now shows the ClinicalTrials.gov record for EOS-2, a completed Phase 3 study comparing two budesonide doses with placebo for maintaining remission in adults with eosinophilic esophagitis. It includes the study design, participant criteria, outcomes, and study dates.
    Difference
    44%
    Check dated 2026-11-07T12:52:20.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2, while the study record area continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:49:50.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces NIH website-transition updates, including a change in terminology from “Artificial Intelligence” to “Super Intelligence” in some NIH content.
    Difference
    1%
    Check dated 2026-10-24T15:16:41.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page, while the study record remains unavailable.
    Difference
    0.2%
    Check dated 2026-10-17T14:59:45.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T15:11:43.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study content with an access-denied message. This indicates the study record is unavailable to view at the moment.
    Difference
    17%
    Check dated 2026-09-19T18:00:10.000Z thumbnail image

Stay in the know with updates to Budesonide in Eosinophilic Esophagitis Maintenance Trial

Enter your email address, and we'll notify you when there's something new on the Budesonide in Eosinophilic Esophagitis Maintenance Trial page.